We are live on ! Find out more
NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

53 hedge funds and large institutions have $50.6M invested in NeuBase Therapeutics, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $868K | Put options by funds: $374K

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

17% more capital invested

Capital invested by funds: $43.1M → $50.6M (+$7.51M)

2% more funds holding

Funds holding: 52 → 53 (+1)

0% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 17

Holders
53
Holders Change
+1
Holders Change %
+1.92%
% of All Funds
1.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
17
Reduced
17
Closed
4
Calls
$868K
Puts
$374K
Net Calls
+$494K
Net Calls Change
-$415K

Top Buyers

1
BFA
BlackRock Fund Advisors
California
+$886K
2
AllianceBernstein
AllianceBernstein
Tennessee
+$865K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$334K
4
LOAMU
Lombard Odier Asset Management (USA)
New York
+$291K
5
BIC
Beach Investment Counsel
Pennsylvania
+$270K

Top Sellers

1
VAM
Visium Asset Management
New York
-$1.15M
2
Millennium Management
Millennium Management
New York
-$438K
3
Goldman Sachs
Goldman Sachs
New York
-$386K
4
SM
Sabby Management
Florida
-$224K
5
Citadel Advisors
Citadel Advisors
Florida
-$68K
Name Holding Trade Value Shares
Change 		Change in
Stake
VAM
1
Visium Asset Management
New York
$8.62M -$1.15M -375 -13%
Millennium Management
2
Millennium Management
New York
$6.9M -$438K -143 -6%
BFA
3
BlackRock Fund Advisors
California
$5.11M +$886K +289 +23%
Vanguard Group
4
Vanguard Group
Pennsylvania
$4.67M +$129K +42 +3%
VM
5
VHCP Management
New York
$3.98M – – –
LOAMU
6
Lombard Odier Asset Management (USA)
New York
$3.82M +$291K +95 +9%
State Street
7
State Street
Massachusetts
$1.81M +$110K +36 +7%
Northern Trust
8
Northern Trust
Illinois
$1.78M -$39.9K -13 -2%
BIT
9
BlackRock Institutional Trust
California
$1.58M -$33.7K -11 -2%
KCM
10
Kennedy Capital Management
Missouri
$1.08M +$18.4K +6 +2%
AllianceBernstein
11
AllianceBernstein
Tennessee
$959K +$865K +282 +5,640%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$939K +$15.3K +5 +2%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$815K +$24.5K +8 +3%
Goldman Sachs
14
Goldman Sachs
New York
$779K -$386K -126 -35%
GBA
15
Garrison Bradford & Associates
New York
$712K +$24.5K +8 +4%
California Public Employees Retirement System
16
California Public Employees Retirement System
California
$608K – – –
TCIM
17
TIAA CREF Investment Management
New York
$607K -$49.1K -16 -8%
PNC Financial Services Group
18
PNC Financial Services Group
Pennsylvania
$576K -$67.4K -22 -11%
BIM
19
BlackRock Investment Management
Delaware
$511K – – –
ACM
20
Aviance Capital Management
Florida
$486K +$52.1K +17 +13%
Deutsche Bank
21
Deutsche Bank
Germany
$445K +$12.3K +4 +3%
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$364K +$334K +109 New
California State Teachers Retirement System (CalSTRS)
23
California State Teachers Retirement System (CalSTRS)
California
$323K – – –
SIP
24
Stoneridge Investment Partners
Pennsylvania
$312K +$61.3K +20 +27%
BIC
25
Beach Investment Counsel
Pennsylvania
$293K +$270K +88 New
1
2 3

NBSE Hedge Fund Activity: Q4 2014 in Review

53 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in NeuBase Therapeutics, Inc. Common Stock (NBSE) for Q4 2014, worth a combined $50.6M — up 17% from $43.1M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new NBSE positions and 4 closed out — a net gain of 3 holders — while 17 added to existing stakes and 17 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $886K. The largest seller was Visium Asset Management, cutting an estimated $1.15M.

  • 53 institutional investors held NeuBase Therapeutics, Inc. Common Stock (NBSE) as of Q4 2014, up from 52 in Q3 2014.
  • Funds reported $50.6M of NeuBase Therapeutics, Inc. Common Stock stock for Q4 2014, up 17% quarter-over-quarter.
  • 7 funds opened new NeuBase Therapeutics, Inc. Common Stock positions in Q4 2014 and 4 closed out, a net change of +3 holders.
  • The largest NeuBase Therapeutics, Inc. Common Stock buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $886K added.
  • The largest NeuBase Therapeutics, Inc. Common Stock seller in Q4 2014 was Visium Asset Management, an estimated $1.15M sold.

Based on aggregated 13F filings for Q4 2014.